Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Drug Repurposing

Mizoram University Researchers Identify Repurposed Drug Targets for COVID-19

A research team from Mizoram University from northwestern India recently published the results of a study titled, ‘Step toward repurposing […]

Mizoram University Researchers Identify Repurpose Drug Targets for COVID-19
4 months ago
Share

Nitazoxanide (NT-300) Trial Comes to Northern Alabama as Cullman Clinical Trials Launches COVID-19 Targeting Study

Another antiparasitic drug has emerged as a potential treatment for COVID-19, and trial site organization in Cullman, Alabama, called Cullman […]

Nitazoxanide (NT-300) Trial Comes to Northern Alabama as Cullman Clinical Trials Launches COVID-19 Targeting Study
6 months ago
Share

Sanford Burnham Prebys Discovers 21 Drugs that Could Treat COVID-19 Including Clofazimine, Hanfangchin A, Apilimod and ONO 5334

Sanford Burnham Prebys Medical Discovery Institute’s Sumit Chanda, PhD led a powerful team of scientists that have identified at least […]

Sanford Burnham Prebys Discovers 21 Drugs that Could Treat COVID-19 Including Clofazimine, Hanfangchin A, Apilimod and ONO 5334
7 months ago
Share

Scripps & Calibr Select AI-based Drug Discovery Platform to Identify Repurposed Drugs targeting COVID-19

Scripps Research, recently ranked as the most influential institution in the world for innovation by Nature Index, selected Repurpose.AI to […]

Scripps & Calibr Select AI-based Drug Discovery Platform to Identify Repurposed Drugs targeting COVID-19
8 months ago
Share

The Move to Repurpose Drugs to Treat the Novel Coronavirus: Status

NBC News recently reported that along with the big push for new COVID-19 vaccines, there are a number of initiatives […]

The Move to Repurpose Drugs to Treat the Novel Coronavirus: Status
12 months ago
Share

Broad Institute’s Drug Repurposing Lab Key for Compelling Study Identifying Nearly Fifty Non-Oncology Drugs that May Fight Cancer

Research scientists from the Broad Institute of MIT, Harvard, and Dana-Farber Cancer Institute have concluded from a recent study that […]

Broad Institute’s Drug Repurposing Lab Key for Compelling Study Identifying Nearly Non-Oncology Drugs that May Fight Cancer
1 year ago
Share

Many Costly Drugs Derived from Older Approved Drugs: Is Innovation Waning?

Drug prices continue to go up

Many Costly Drugs Derived from Older Approved Drugs Is Innovation Waning
1 year ago
Share

George Washington University Study Asks: Can Nilotinib be Repurposed from use for Specific Cancer to use for Parkinson’s Disease?

There is tremendous value in identifying new purposes for existing drugs. Recently, Georgetown University Medical Center (GUMC) embarked on a project […]

George Washington University Study Asks Can Nilotinib be Repurposed from use for Specific Cancer to use for Parkinson’s Disease
1 year ago
Share

CURE ID Launched by FDA to Open up Crowdsourcing for Repurposing of Approved Drugs for Novel Uses in Rare Disease

The U.S. Food and Drug Administration announced the launch of CURE ID, an internet-based repository that enables the clinical community to […]

CURE ID Launched by FDA to Open up Crowdsourcing for Repurposing of Approved Drugs for Novel Uses in Rare Disease
1 year ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.